vs
Arbutus Biopharma Corp（ABUS）与ACCESS Newswire Inc.（ACCS）财务数据对比。点击上方公司名可切换其他公司
Arbutus Biopharma Corp的季度营收约是ACCESS Newswire Inc.的1.9倍（$10.7M vs $5.8M），Arbutus Biopharma Corp净利率更高（23.5% vs -9.9%，领先33.4%），Arbutus Biopharma Corp同比增速更快（522.2% vs -0.5%），过去两年ACCESS Newswire Inc.的营收复合增速更高（2.0% vs -13.2%）
Arbutus生物制药是一家公开上市的加拿大生物制药企业，专长于脂质体药物递送与RNA干扰技术，目前主要开展针对乙型肝炎感染的治疗药物研发工作，在抗病毒新药研发领域拥有深厚的技术积累。
ACCESS通讯社是一家新闻通稿分发服务商，总部位于芝加哥，1954年成立，最初通过电传设备为企业向新闻机构电子传输新闻稿，创始人赫伯特·穆舍勒曾在曼哈顿家中运营该业务长达15年，公司几经转手后，于2015年被Cision集团宣布收购。
ABUS vs ACCS — 直观对比
营收规模更大
ABUS
是对方的1.9倍
$5.8M
营收增速更快
ABUS
高出522.7%
-0.5%
净利率更高
ABUS
高出33.4%
-9.9%
两年增速更快
ACCS
近两年复合增速
-13.2%
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.7M | $5.8M |
| 净利润 | $2.5M | $-576.0K |
| 毛利率 | — | 77.4% |
| 营业利润率 | 13.9% | -13.1% |
| 净利率 | 23.5% | -9.9% |
| 营收同比 | 522.2% | -0.5% |
| 净利润同比 | 112.7% | 94.4% |
| 每股收益（稀释后） | $0.01 | $-0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABUSACCS
| Q4 25 | — | $5.8M | ||
| Q3 25 | — | $5.7M | ||
| Q2 25 | $10.7M | $5.6M | ||
| Q1 25 | — | $5.5M | ||
| Q4 24 | — | $5.8M | ||
| Q3 24 | — | $5.6M | ||
| Q2 24 | — | $6.0M | ||
| Q1 24 | — | $5.6M |
净利润ABUSACCS
| Q4 25 | — | $-576.0K | ||
| Q3 25 | — | $-45.0K | ||
| Q2 25 | $2.5M | $-475.0K | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | — | $-10.2M | ||
| Q3 24 | — | $-466.0K | ||
| Q2 24 | — | $7.0K | ||
| Q1 24 | — | $-139.0K |
毛利率ABUSACCS
| Q4 25 | — | 77.4% | ||
| Q3 25 | — | 74.6% | ||
| Q2 25 | — | 76.2% | ||
| Q1 25 | — | 78.0% | ||
| Q4 24 | — | 75.2% | ||
| Q3 24 | — | 75.0% | ||
| Q2 24 | — | 77.2% | ||
| Q1 24 | — | 75.1% |
营业利润率ABUSACCS
| Q4 25 | — | -13.1% | ||
| Q3 25 | — | -3.2% | ||
| Q2 25 | 13.9% | -4.4% | ||
| Q1 25 | — | -12.4% | ||
| Q4 24 | — | -245.8% | ||
| Q3 24 | — | -10.7% | ||
| Q2 24 | — | -8.8% | ||
| Q1 24 | — | -15.5% |
净利率ABUSACCS
| Q4 25 | — | -9.9% | ||
| Q3 25 | — | -0.8% | ||
| Q2 25 | 23.5% | -8.5% | ||
| Q1 25 | — | 98.4% | ||
| Q4 24 | — | -175.0% | ||
| Q3 24 | — | -8.3% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | -2.5% |
每股收益（稀释后）ABUSACCS
| Q4 25 | — | $-0.16 | ||
| Q3 25 | — | $-0.01 | ||
| Q2 25 | $0.01 | $-0.12 | ||
| Q1 25 | — | $1.40 | ||
| Q4 24 | — | $-2.66 | ||
| Q3 24 | — | $-0.12 | ||
| Q2 24 | — | $0.00 | ||
| Q1 24 | — | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $37.4M | $3.0M |
| 总债务越低越好 | $0 | — |
| 股东权益账面价值 | $83.0M | $30.3M |
| 总资产 | $103.3M | $42.0M |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资ABUSACCS
| Q4 25 | — | $3.0M | ||
| Q3 25 | — | $3.3M | ||
| Q2 25 | $37.4M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $4.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
总债务ABUSACCS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $0 | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ABUSACCS
| Q4 25 | — | $30.3M | ||
| Q3 25 | — | $30.8M | ||
| Q2 25 | $83.0M | $30.7M | ||
| Q1 25 | — | $30.9M | ||
| Q4 24 | — | $25.2M | ||
| Q3 24 | — | $35.3M | ||
| Q2 24 | — | $35.4M | ||
| Q1 24 | — | $35.2M |
总资产ABUSACCS
| Q4 25 | — | $42.0M | ||
| Q3 25 | — | $44.0M | ||
| Q2 25 | $103.3M | $45.6M | ||
| Q1 25 | — | $47.3M | ||
| Q4 24 | — | $50.6M | ||
| Q3 24 | — | $61.7M | ||
| Q2 24 | — | $62.8M | ||
| Q1 24 | — | $64.4M |
负债/权益比ABUSACCS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.7M | $258.0K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | 0.0% |
| 现金转化率经营现金流/净利润 | -6.24× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ABUSACCS
| Q4 25 | — | $258.0K | ||
| Q3 25 | — | $-582.0K | ||
| Q2 25 | $-15.7M | $135.0K | ||
| Q1 25 | — | $747.0K | ||
| Q4 24 | — | $866.0K | ||
| Q3 24 | — | $1.5M | ||
| Q2 24 | — | $-190.0K | ||
| Q1 24 | — | $986.0K |
自由现金流ABUSACCS
| Q4 25 | — | — | ||
| Q3 25 | — | $-590.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $735.0K | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $1.5M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $970.0K |
自由现金流率ABUSACCS
| Q4 25 | — | — | ||
| Q3 25 | — | -10.3% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 13.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 26.5% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 17.4% |
资本支出强度ABUSACCS
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.3% |
现金转化率ABUSACCS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -6.24× | — | ||
| Q1 25 | — | 0.14× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -27.14× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABUS
暂无分部数据
ACCS
| Cost To Deliver Products | $3.1M | 54% |
| Employee Costs | $1.7M | 29% |
| Other | $1.0M | 17% |
